Your Basket 0

<<First <Prev    Next> Last>>
Search Results for:
Catalogue No Partner Description Species Application
HY-100714-10mg MedChemexpress LLC DL-AP5 [CAS 76326-31-3] COVID-19-immunoregulation
HY-100714-25mg MedChemexpress LLC DL-AP5 [CAS 76326-31-3] COVID-19-immunoregulation
HY-100714-5mg MedChemexpress LLC DL-AP5 [CAS 76326-31-3] COVID-19-immunoregulation
HY-100714-50mg MedChemexpress LLC DL-AP5 [CAS 76326-31-3] COVID-19-immunoregulation
HY-101054-10mg MedChemexpress LLC NQ301 [CAS 130089-98-4] COVID-19-immunoregulation
HY-101054-100mg MedChemexpress LLC NQ301 [CAS 130089-98-4] COVID-19-immunoregulation
HY-101054-25mg MedChemexpress LLC NQ301 [CAS 130089-98-4] COVID-19-immunoregulation
HY-101054-5mg MedChemexpress LLC NQ301 [CAS 130089-98-4] COVID-19-immunoregulation
HY-101054-50mg MedChemexpress LLC NQ301 [CAS 130089-98-4] COVID-19-immunoregulation
HY-101056-10mg MedChemexpress LLC Brensocatib [CAS 1802148-05-5] COVID-19-immunoregulation
HY-101056-100mg MedChemexpress LLC Brensocatib [CAS 1802148-05-5] COVID-19-immunoregulation
HY-101056-5mg MedChemexpress LLC Brensocatib [CAS 1802148-05-5] COVID-19-immunoregulation
HY-101056-50mg MedChemexpress LLC Brensocatib [CAS 1802148-05-5] COVID-19-immunoregulation
HY-103157-10mg MedChemexpress LLC PD146176 [CAS 4079-26-9] COVID-19-immunoregulation
HY-103157-100mg MedChemexpress LLC PD146176 [CAS 4079-26-9] COVID-19-immunoregulation
HY-103157-5mg MedChemexpress LLC PD146176 [CAS 4079-26-9] COVID-19-immunoregulation
HY-103157-50mg MedChemexpress LLC PD146176 [CAS 4079-26-9] COVID-19-immunoregulation
HY-108573-10mg MedChemexpress LLC P-1075 [CAS 60559-98-0] COVID-19-immunoregulation
HY-108573-100mg MedChemexpress LLC P-1075 [CAS 60559-98-0] COVID-19-immunoregulation
HY-108573-2mg MedChemexpress LLC P-1075 [CAS 60559-98-0] COVID-19-immunoregulation
HY-108573-5mg MedChemexpress LLC P-1075 [CAS 60559-98-0] COVID-19-immunoregulation
HY-108573-50mg MedChemexpress LLC P-1075 [CAS 60559-98-0] COVID-19-immunoregulation
HY-108738-1mg MedChemexpress LLC Daclizumab [CAS 152923-56-3] COVID-19-immunoregulation
HY-108738-10mg MedChemexpress LLC Daclizumab [CAS 152923-56-3] COVID-19-immunoregulation
HY-108738-5mg MedChemexpress LLC Daclizumab [CAS 152923-56-3] COVID-19-immunoregulation